{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T21:25:20Z","timestamp":1695331520915},"reference-count":40,"publisher":"Japan Society for Clinical Immunology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn.J.clin.Immun","Jpn. J. Clin. Immunol."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2177\/jsci.38.37","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T22:07:54Z","timestamp":1425938874000},"page":"37-44","source":"Crossref","is-referenced-by-count":4,"title":["Niacin deficiency and cutaneous immunity"],"prefix":"10.2177","volume":"38","author":[{"given":"Atsuko","family":"IKENOUCHI-SUGITA","sequence":"first","affiliation":[{"name":"Swiss Institute of Allergy and Asthma Research, Davos, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"SUGITA","sequence":"additional","affiliation":[{"name":"Swiss Institute of Allergy and Asthma Research, Davos, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","unstructured":"1) Skokowa, J., et al.: NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway. <i>Nat Med<\/i>. <b>15<\/b>: 151-158, 2009."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Mercieri, M., Mercieri, A.: Images in clinical medicine: A photosensitive dermatitis in the intensive care unit. <i>N Engl J Med<\/i>. <b>364<\/b>: 361, 2011.","DOI":"10.1056\/NEJMicm1003313"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Dunbar, R.L., Gelfand, J.M.: Seeing red: flushing out instigators of niacin-associated skin toxicity. <i>J Clin Invest<\/i>. <b>120<\/b>: 2651-2655, 2010.","DOI":"10.1172\/JCI44098"},{"key":"4","unstructured":"4) Benavente, C.A., et al.: NAD in skin: therapeutic approaches for niacin. <i>Curr Pharm Des<\/i>. <b>15<\/b>: 29-38, 2009."},{"key":"5","unstructured":"5) Offermanns, S., et al.: International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B). <i>Pharmacol Rev<\/i>. <b>63<\/b>: 269-290, 2011."},{"key":"6","unstructured":"6) Soga, T., et al.: Molecular identification of nicotinic acid receptor. <i>Biochem Biophys Res Commun<\/i>. <b>303<\/b>: 364-369, 2003."},{"key":"7","unstructured":"7) Chai, J.T., et al.: GPR109A and vascular inflammation. <i>Curr Atheroscler Rep<\/i>. <b>15<\/b>: 325, 2013."},{"key":"8","unstructured":"8) Yousefi, S., et al.: cDNA representational difference analysis of human neutrophils stimulated by GM-CSF. <i>Biochem Biophys Res Commun<\/i>. <b>277<\/b>: 401-409, 2000."},{"key":"9","unstructured":"9) Schaub, A., et al.: PUMA-G, an IFN-gamma-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily. <i>Eur J Immunol<\/i>. <b>31<\/b>: 3714-3725, 2001."},{"key":"10","unstructured":"10) Hanson, J., et al.: Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice. <i>J Clin Invest<\/i>. <b>120<\/b>: 2910-2919, 2010."},{"key":"11","unstructured":"11) Chai, J.T., et al.: Nicotinic acid receptor GPR109A is down-regulated in human macrophage-derived foam cells. <i>PLoS One<\/i>. <b>8<\/b>: e62934, 2013."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Ding, Y., et al.: Effect of niacin on lipids and glucose in patients with type 2 diabetes: A meta-analysis of randomized, controlled clinical trials. <i>Clin Nutr<\/i>, 2014.","DOI":"10.1016\/j.clnu.2014.09.019"},{"key":"13","unstructured":"13) Altschul, R., et al.: Influence of nicotinic acid on serum cholesterol in man. <i>Arch Biochem Biophys<\/i>. <b>54<\/b>: 558-559, 1955."},{"key":"14","unstructured":"14) Lauring, B., et al.: Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression. <i>Sci Transl Med<\/i>. <b>4<\/b>: 148ra115, 2012."},{"key":"15","unstructured":"15) Lukasova, M., et al.: Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials. <i>Trends Pharmacol Sci<\/i>. <b>32<\/b>: 700-707, 2011."},{"key":"16","unstructured":"16) Digby, J.E., et al.: Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin. <i>Atherosclerosis<\/i>. <b>209<\/b>: 89-95, 2010."},{"key":"17","unstructured":"17) Singh, N., et al.: Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. <i>Immunity<\/i>. <b>40<\/b>: 128-139, 2014."},{"key":"18","unstructured":"18) Hashimoto, T., et al.: ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. <i>Nature<\/i>. <b>487<\/b>: 477-481, 2012."},{"key":"19","unstructured":"19) Rahman, M., et al.: The beta-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. <i>Nat Commun<\/i>. <b>5<\/b>: 3944, 2014."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Ishii, N., Nishihara, Y.: Pellagra among chronic alcoholics: clinical and pathological study of 20 necropsy cases. <i>J Neurol Neurosurg Psychiatry<\/i>. <b>44<\/b>: 209-215, 1981.","DOI":"10.1136\/jnnp.44.3.209"},{"key":"21","unstructured":"21) Hegyi, J., et al.: Pellagra: dermatitis, dementia, and diarrhea. <i>Int J Dermatol<\/i>. <b>43<\/b>: 1-5, 2004."},{"key":"22","unstructured":"22) Wan, P., et al.: Pellagra: a review with emphasis on photosensitivity. <i>Br J Dermatol<\/i>. <b>164<\/b>: 1188-1200, 2011."},{"key":"23","unstructured":"23) Murray, M.F., et al.: HIV infection decreases intracellular nicotinamide adenine dinucleotide [NAD]. <i>Biochem Biophys Res Commun<\/i>. <b>212<\/b>: 126-131, 1995."},{"key":"24","unstructured":"24) Tremeschin, M.H., et al.: Niacin nutritional status in HIV type 1-positive children: preliminary data. <i>J Pediatr Gastroenterol Nutr<\/i>. <b>44<\/b>: 629-633, 2007."},{"key":"25","unstructured":"25) Seow, H.F., et al.: Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19. <i>Nat Genet<\/i>. <b>36<\/b>: 1003-1007, 2004."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kiss, F., Anstey, A.V.: A review of UVB-mediated photosensitivity disorders. <i>Photochem Photobiol Sci<\/i>. <b>12<\/b>: 37-46, 2013.","DOI":"10.1039\/C2PP25275A"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Karthikeyan, K., Thappa, D.M.: Pellagra and skin. <i>Int J Dermatol<\/i>. <b>41<\/b>: 476-481, 2002.","DOI":"10.1046\/j.1365-4362.2002.01551.x"},{"key":"28","unstructured":"28) Sugita, K., et al.: Chronic actinic dermatitis associated with adult T-cell leukemia. <i>J Am Acad Dermatol<\/i>. <b>52<\/b>: 38-40, 2005."},{"key":"29","unstructured":"29) Sugita, K., et al.: Prostaglandin E(2) is critical for the development of niacin-deficiency-induced photosensitivity via ROS production. <i>Sci Rep<\/i>. <b>3<\/b>: 2973, 2013."},{"key":"30","unstructured":"30) Yamaguchi, T., et al.: Galectin-7, induced by cis-urocanic acid and ultraviolet B irradiation, down-modulates cytokine production by T lymphocytes. <i>Exp Dermatol<\/i>. <b>22<\/b>: 840-842, 2013."},{"key":"31","unstructured":"31) Vasantha, L.: Histidine urocanic acid and histidine alpha-deaminase in the stratum corneum in pellagrins. <i>Indian J Med Res<\/i>. <b>58<\/b>: 1079-1084, 1970."},{"key":"32","unstructured":"32) Barresi, C., et al.: Increased sensitivity of histidinemic mice to UVB radiation suggests a crucial role of endogenous urocanic acid in photoprotection. <i>J Invest Dermatol<\/i>. <b>131<\/b>: 188-194, 2011."},{"key":"33","unstructured":"33) Baden, H.P., et al.: Epidermis in histidinemia. <i>Arch Dermatol<\/i>. <b>100<\/b>: 432-435, 1969."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Rapaport, M.J.: Pellagra in a patient with anorexia nervosa. <i>Arch Dermatol<\/i>. <b>121<\/b>: 255-257, 1985.","DOI":"10.1001\/archderm.1985.01660020113032"},{"key":"35","unstructured":"35) Wennersten, G., Brunk, U.: Cellular aspects of phototoxic reactions induced by kynurenic acid. I. Establishment of an experimental model utilizing in vitro cultivated cells. <i>Acta Derm Venereol<\/i>. <b>57<\/b>: 201-209, 1977."},{"key":"36","unstructured":"36) Kabashima, K., et al.: Prostaglandin E2 is required for ultraviolet B-induced skin inflammation via EP2 and EP4 receptors. <i>Lab Invest<\/i>. <b>87<\/b>: 49-55, 2007."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Kabashima, K., Miyachi, Y.: Prostanoids in the cutaneous immune response. <i>J Dermatol Sci<\/i>. <b>34<\/b>: 177-184, 2004.","DOI":"10.1016\/j.jdermsci.2003.11.008"},{"key":"38","unstructured":"38) Honda, T., et al.: Prostanoid receptors as possible targets for anti-allergic drugs: recent advances in prostanoids on allergy and immunology. <i>Curr Drug Targets<\/i>. <b>11<\/b>: 1605-1613, 2010."},{"key":"39","unstructured":"39) Nakane, H., et al.: High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. <i>Nature<\/i>. <b>377<\/b>: 165-168, 1995."},{"key":"40","unstructured":"40) Kuwamoto, K., et al.: Possible involvement of enhanced prostaglandin E2 production in the photosensitivity in xeroderma pigmentosum group A model mice. <i>J Invest Dermatol<\/i>. <b>114<\/b>: 241-246, 2000."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":["\u30ca\u30a4\u30a2\u30b7\u30f3\u6b20\u4e4f\u3068\u76ae\u819a\u514d\u75ab"],"language":"en","deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T20:21:04Z","timestamp":1566418864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/38\/1\/38_37\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.38.37","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}